Janice Kranz
Principal investigator, leads EIKONIZO THERAPEUTICS, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$810KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $810K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 30, 2020 | NIH | SBIR Phase I Mechanistic Validation of Selective Brain-Penetrant HDAC6 Inhibitors as a Disease- Modifying Treatment for Tauopathies including Alzheimer's Disease | $510K | EIKONIZO THERAPEUTICS, INC. |
| Sep 1, 2020 | NIH | SBIR Phase I Targeting HDAC6 to Modulate Titin Stiffness for Dilated Cardiomyopathy Therapy | $300K | EIKONIZO THERAPEUTICS, INC. |
Peer ranks
Federal funding#1,968
Awards as PI#1,252
Patents#273
Companies
- EIKONIZO THERAPEUTICS, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.